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IT is well established that orotic acid is a physiological precursor of the uracil
in ribonucleic acid (RNA), the injection of labelled orotic acid leading to the
appearance of the label in uridine 5'-phosphate derivatives and subsequently in
RNA (Hurlbert and Potter, 1954). A pilot study has now been made of the
incorporation of injected [6_14C] orotic acid into these ribonucleotides and into
RNA, with hepatomas and with " precancerous " liver obtained by a short period
of azo-dye feeding. Except in the study of ribonucleotides, the tissue samples
were separated by differential centrifugation into four RNA-containing fractions
-nuclear (containing some unbroken cells), mitochondrial, microsomal and super-
natant-which were studied separately with respect to the labelling of RNA and
also to the levels ofRNA. The data for labelling ofribonucleotides are considered
in conjunction with data for their levels which are given in the preceding paper
(Reid and Lotz, 1958).
EXPERIMENTAL
Animals and administration of isotope.-As in the experiments of Reid and
O'Neal (1956), the rats were albino males, and the experimental animals had been
fed on a diet containing 3'-methyl-4-dimethyl-aminoazobenzene. The carcinogen
was withdrawn at least 10 days before autopsy or, in the case of the " precancer-
ous " liver obtained by short periods of dye feeding (23, 28 or 38 days), 2, 1 or 4
days beforehand. For several days before autopsy, the rats were kept inindividual
cages on a constant food intake, no food being given on the last day. As in the
preceding paper (Reid and Lotz, 1958), the rats were killed by decapitation and
tissue samples were removed and frozen quickly for the study ofribonucleotides;
the samples from rats with hepatomas included not only tumour tissue, but also
"liver distant from tumours ".
The [6-14C] orotic acid used in the study ofprecancerous liver, as in a previous
study (Reid, O'Neal, Stevens and Burnop, 1956), was prepared in this Institute
by Dr. V. C. E. Burnop and had a specific activity of 6-4 4ac/mg. The [6-14C]
orotic acid used in the study of hepatomas was obtained from the Radiochemical
Centre, Amersham, and had a specific activity of 55 ,tc/mg. The orotic acid was
injected intraperitoneally at pH 8; the dose was within the range 6-66 utc, high
doses (below " saturation level " (Keller, Zamecnik and Loftfield, 1954)) being
given to rats with hepatomas.
The rats were killed 2*5 hours after the injection. This time interval was such
that, from previous experience (Reid et al., 1956; Reid and Stevens, 1957, 1958;INCORPORATION OF OROTIC ACID
see also Hurlbert and Potter (1954), Hecht and Potter (1956), and Fig. 1 below),
the injected label would be almost entirely present as nucleotide uracil (with only
a trace in cytosine)-mainly in acid-soluble uridine nucleotides and in nuclear
RNA, but with a measurable amount in cytoplasmic RNA. Under these condi-
tions, much information can be gained without the use ofdifferent time intervals.
Tissue fractions.-For the study of RNA, differential centrifugation was per-
formed as described in the preceding paper (Reid and Lotz, 1958), to give nuclear,
mitochondrial, microsomal and supernatant fractions. In a few experiments
(Table I), supernatant fractions were further centrifuged to sediment an " ultra-
centrifugal fraction" (Reid et al., 1956). The " nuclear" fraction, sedimented at
600 g, contained some unbroken cells, but its radioactivity was substantially
attributable to nuclear RNA, the labelling of which was high in relation to cyto-
plasmic RNA at the time interval chosen. Each fraction was freed from acid-
soluble constituents, defatted, dried, weighed, ground, and counted at infinite
thickness as in previous experiments (Reid et al., 1956; Reid and Stevens, 1957).
Forthe determination ofthe totalradioactivity ofthe acid-soluble constituents,
the supernatant fluid (" acid-soluble fraction ") obtained on adding perchloric
acid to the supernatant fraction and centrifuging was neutralized with KOH
solution, centrifuged to removeKC104, andplated at infinitethinness onduralumin
planchets (Reid and Stevens, 1958). The content of RNA in defatted tissue frac-
tions was determined by measuring the extinction of acidified alkaline digests
(Reid et al., 1956). In a few experiments, " polymerized " RNA (Lowe, 1955) was
isolated from supernatant fractions according to Stevens and Reid (1956) before
the removal of acid-soluble and lipid constituents.
Acid-soluble nucleotides.-Solutions of the uridine nucleotides isolated as
described in the preceding paper (Reid and Lotz, 1958) were plated on duralumin
planchets, and counted at infinite thinness to furnish values for specific radio-
activity.
RESULTS
Yield of defatted material.-In Table I, experimental rats have been compared
with their controls with respect to the yield of solid (mainly protein) obtained
from the tissue fractions after removal ofacid-soluble and lipid constituents prior
to counting. Hepatomas showed a marked decrease in microsomal solid; with the
mitochondrial and supernatant fraction the decreases were not significant. Pre-
cancerous liver showed decreases in yield with the " nuclear " fraction (containing
unbroken cells as well as nuclei) and with the mitochondrial fraction.
LevelofRNA.-Hepatomas showed amarked and consistent fallin microsomal
RNA, although not in the " ultramicrosomal " RNA of the ultracentrifugal
fraction (Table I). The RNA ofthe " nuclear "fraction showed an increase which
was, however, insignificant. Precancerous liver showed decreased amounts of
RNA in the nuclear, mitochondrial and microsomal fractions. Here it should be
pointed out that contaminating RNA from other cell elements may be present
not only in the nuclear fraction, as already mentioned, but also in the mitochon-
drial fraction (Birbeck and Reid, 1956; Harel, Jacob and Moule, 1957). It should
also be noted that supernatant-fraction RNA (some of which could be sedimented
in the ultracentrifuge) formed a high proportion ofthe cytoplasmic RNA because,
as Reid and Stevens (1957, 1958) have discussed, it was considered advantageous
to use a relatively low gravitational force in sedimenting the microsomal fraction.
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A few analyses (not shown in Table I) on supernatant fractions for " poly-
merized " RNA, which under some circumstances may change disproportionately
with " total " RNA (Lowe, 1955), gave no evidence of abnormal values in hepa-
tomas or precancerous liver.
TABLE I.-Content ofDefatted Solid and ofRNA in Tissue Fractions
The values are calculated as mg./g. original tissue. The standard error
is givenaftereach meandifference; thenumber of degrees offreedom, and
theprobabilitythatthedifference couldbedueto chance (if < 10per cent),
are given parenthetically.
Prolonged azo-day feeding
I' -A A
Fraction
" Nuclear "
Mitochondrial
Microsomal
Supernatant
Ultracentrifugal (from
supernatant)
" Nuclear "
Mitochondrial
Microsomal
Supernatant
Ultracentifugal (from
supernatant)
Control
rats,
mean
value
53
39
33
90
22
3-0
1*3
2-8
3-2
1-8
Experimental rats:
difference from
corresponding controls
Liver distant
Hepatoma from tumours
Yield of Defatted Solid
+7 -20 (0)
±15 (3)
-24
±10-1 (2)
-20
±4-4
(2; P<5%)
-29
±9-4 (2)
-7
±2-4 (2)
-6 (0)
-2 (0)
-3 (0)
Amount ofRNA
+2-0 +0-7 (1)
±0-96 (3)
-0 1 +0-3
±0-20 (3) ±0411 (3)
-1-4
±0-21
(6; P<0-1%)
0
±0-32 (6)
-0-15
±0-11 (2)
-0-15
±0418 (3)
+0-1
+0-25 (3)
Brief azo-dye feeding
A-
Experimental
rats (i.e. " pre-
Control cancerous "liver):
rats, difference from
mean corresponding
value controls
76 -20
±3-7
(3; P<2-5%)
43 -12
±2-4
(3; P<2-5%)
23 -1-5
±7-2 (3)
87 -8
± 14 (3)
5 0 -0-9
±0-30
(3; P<10%)
1-75 -0-35
+0-065
(6; P<0-5%)
2-3 -0-47
+0-19
(6; P< 5%)
3-5 -0-25
±0-51 (6)*
* The amount of RNA may have been governed by the period of dye feeding, the individual
differencesbeing: 23 days, -2-2 and -1-7; 28 days, -0-45, +0-4 and -0-4; 38 days, +0-3
and +1-9.
Recovery of label in RNA after injection of [6-14C] orotic acid.-Considerable
variations in the extent of labelling of RNA may occur even with normal liver
(Hurlbert and Potter, 1954). To minimize the effect of such variations, the re-
coveries for each rat have been expressed relative to the recovery in the acid-
soluble fraction (containing labelled precursors of RNA) from the same tissue
sample. Some difference in behaviour (absorption rate ?) was encountered be-
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tween two batches of orotic acid: the recoveries in RNA were higher with the
batch used in the study of hepatomas than with that used in the studies on
precancerous liver (as is evident from the values for control rats in Fig. 1).
Fig. 1 shows that the labelling of RNA, relative to that of the acid-soluble
fraction, tended to be high with hepatomas, notably in the nuclear fraction, the
whole cytoplasmic fraction and the supematant fraction derived therefrom. The
converse was found with precancerous liver.
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Fia. 1.-Recovery of radioactivity in tissue fractions [(a) nuclear, whole cytoplasmic, and
supernatant fractions; (b) mitochondrial and microsomal fractions] relative to recovery
in acid-soluble fraction (from same amount of tissue), in rats given [6-14C] orotic acid.
C = control rats studied simultaneously with the experimental rats; H = hepatoma;
D = liver distant from tumours; P28 andP38 = 23 and 38 days of dye feeding. The dots
denote individual rats.
In Fig. 1-3, direct comparison should not be made between experiments on precancerous
liver and experiments on hepatomas, since different batches of orotic acid were used (see
text).432 E. REID
Closer analysis of RNA labelling data.-The reference point in Fig. 1 being the
acid-soluble fraction, in which much of the label was still present at the time of
autopsy, changes in RNA labelling connote changes in actual rates of RNA syn-
thesis from the acid-soluble precursor if, and only if, the amount of radioactivity
in the whole acid-soluble fraction truly reflects the specific radioactivity of
the actual precursor. Some data bearing on this question were obtained in a
few experiments (as reported below) in which nucleotide analyses were performed
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FIa. 2.-Amount of radioactivity (per g. tissue), per unit specific radioactivity of uridine
diphosphate isolated from the same tissue samples (pooled tissue from 2 rats), in tissue
fractions from precancerous liver, hepatomas or liver distant from tumours. For the
hepatomas, the lower dot in each case corresponds to one experiment, and the higher dot to
a second experiment.
with pooled tissue samples from pairs of rats (the study of individual rats being
impracticable).
Taking as the reference substance uridine diphosphate, provisionally assumed
to be the actual precursor of RNA (Grunberg-Manago, Oritz and Ochoa, 1955;
Herbert, Hecht and Potter, 1957; see also Discussion), the changes in RNA
labelling (Fig. 2) are somewhat different from those shown in Fig. 1, because
experimental and control rats did not in fact show constancy in the ratio of the
specific activity ofthis nucleotide to the labelling ofthe whole acid-soluble fraction.
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This ratio was below the control value for one pair of hepatomas (and for pre-
cancerous liver or liver distant from tumours) and above the control value for the
other pair of hepatomas studied. It appears then, from the data for hepatomas
(Fig. 2) that the conclusion suggested byFig. 1 (a) that there is increased synthesis
of nuclear- and supernatant-fraction RNA must be treated with reserve, at least
as regards the nuclear fraction. It further appears that the conclusion suggested
by Fig. 1 (a) for precancerous liver, that there is decreased synthesis of nuclear-
and supernatant-fraction RNA, is incorrect.
Data for mitochondrial fractions are omitted from Fig. 2 since, as already
stated, their RNA is not entirely attributable to mitochondria. With microsomal
fractions there is the difficulty that the RNA is probably formed not directly from
the acid-soluble precursor, but from RNA in the nuclear or supernatant fraction
(Jeener and Szafarz, 1950; Barnum, Huseby and Vermund, 1953; Reid and
Stevens, 1957, 1958). The values for microsomal RNA in hepatomas (Fig. 2)
should therefore be considered in relation to the specific activities of nuclear- and
supernatant-fraction RNA. The values shown in Fig. 2 for the recovery of label
in the latter fractions are a valid measure ofspecific activity, the amounts ofRNA
in these fractions being essentially normal in the experimental rats here studied;
since these values were increased (except that for nuclear RNA in one pair of
hepatomas), it appears likely that there is decreased rather than increased syn-
thesis of microsomal RNA.
Labelling of acid-soluble nucleotides.-Not only uridine diphosphate, but also
other uridine nucleotides in the acid-soluble fraction were analysed for amount
(Reid and Lotz, 1958) and for specific radioactivity. To assist in the interpre-
tation ofthe data, the values for precancerous liver (Fig. 3 (a)) are plotted relative
to those for uridine diphosphate, since the amount of this nucleotide in pre-
cancerous liver was essentially normal (Reid and Lotz, 1958). It is not possible
to express the values in terms of those for orotic acid itself, which is very rapidly
metabolized and is scarcely detectable in normal liver (Hurlbert and Potter, 1954).
Since uridine nucleotides undergo various interconversions (Leloir, 1956), the
results given below can be interpreted only tentatively.
In contrast with uridine diphosphate, uridine monophosphate and uridine
diphosphate-acetylglucosamine were shown in Fig. 1 of the preceding paper
(Reid and Lotz, 1958) to be increased in amount in precancerous liver (23 days of
dye feeding). That their rate of synthesis may indeed be increased is suggested
by the further finding, shown in Fig. 3 (a), that their specific activities were high
relative to uridine diphosphate. Fig. 3 (a), considered in conjunction with Fig. 1
in the paper of Reid and Lotz (1958), further suggests that the rate of synthesis
may be increased with uridine diphosphate-glucuronic acid, but somewhat.
decreased with uridine diphosphate-glucose.
With hepatomas, uridine diphosphate-glucose was taken as the reference sub-
stance, since its level was essentially normal whereas that of uridine diphosphate
was increased (Reid and Lotz, 1958). Although the level of the latter nucleotide
was increased by about 50 per cent, its specific radioactivity as expressed in Fig.
3 (b) was decreased by about 50 per cent. It therefore appears unlikely that the
increase in level is attributable to increased rate ofsynthesis. The same argument
applied to uridine triphosphate, the level of which was likewise increased in
hepatomas. The absence of a change in the level, in hepatomas, of uridine mono-
phosphate or of uridine diphosphate-acetylglucosamine is in accord with the
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apparently normal values obtained for specific radioactivity (Fig. 3 (b)). On the
other hand, uridine diphosphate-glucuronic acid is decreased in amount, with no
increase in its specific radioactivity; here it appears that the rate of synthesis
may in fact be decreased.
The results for nucleotides in liver distant from tumours are also related to
those for uridine diphosphate-glucose, since its level was normal this tissue, as in
the hepatomas. As with hepatomas, it can be argued from Fig. 3 (b) that the
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FIG. 3.-Specific radioactivities (on molar basis) of uridine nucleotides (a) from precancerous
liver, relative to radioactivity of uridine diphosphate isolated simultaneously, and (b) from
hepatomas (2 experiments, except for uridine diphosphate-glucuronic acid) or from liver
distant from tumours, relative to radioactivity of uridine diphosphate-glucose isolated
simultaneously.
increase in the amount of uridine diphosphate (Reid and Lotz, 1958) is not attri-
butable to an increase in rate ofsynthesis. The levels ofother uridine nucleotides
were essentially normal inliver distant from tumours, and the radioactivity values
were also normal except for uridine triphosphate.
Free uracil or uridine, such as might arise from the catabolism of uridine
nucleotides, is not adsorbed on the resin used for chromatography of the acid-
soluble fraction, and it is reasonable to suppose that any radioactivity in the non-
adsorbed material is largely attributable to one or both of these compounds.
Analyses on the non-adsorbed fraction (not given in Fig. 3) showed that with
hepatomas, although not with liver distant from these, there was a three-fold
increase in the amount of radioactivity, relative to that in uridine diphosphate-
glucose. Interpretation ofthis finding must await further study.
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DISCUSSION
The apparent changes in yield of defatted material (Fig. 1), this material
being mainly protein, are essentially in accord with published observations on the
levels of protein in particulate and supernatant fractions during carcinogenesis
(Price, Miller, Miller and Weber, 1950; Schneider, Hogeboom, Shelton and
Striebich, 1953; Reid and O'Neal, 1956; Petermann, Mizen and Hamilton, 1956;
Allard, de Lamirande and Cantero, 1957, cf. Grant and Rees, 1958). Direct
comparisons with published work are, however, difficult because of differences in
technique and especially in centrifugation conditions.
The same difficulty applies in considering the values for RNA levels, which
(for reasons already indicated) were relatively high in the "nuclear" and super-
natant fractions as now prepared. Changes in RNA levels during azo-dye carcino-
genesis have been reported from a number of laboratories. Thus, Price et al.
(1950) found decreased amounts of RNA in mitochondrial and microsomal frac-
tions and somewhat increased amounts in nuclear and supernatant fractions,
with rats fed 3'-methyl-4-dimethylaminoazobenzene for four weeks. Similar
decreases in RNA were found with mitochondrial fractions by Schneider et al.
(1953) and by Cunningham, Griffin and Luck (1950), and with microsomal frac-
tions by Fiala, Fiala and Sproul (1957) who also found a rise in supernatant-
fraction RNA at a later stage of dye feeding. The fall in cytoplasmic basophilia
observed in cytological studies (Opie, 1946; Spain, 1956) is in accordance with
the reported initial fall in microsomal RNA. In the present study, however, pre-
cancerous liver showed only small decreases in the RNA of mitochondrial and
microsomal fractions, and there were no increases in the RNA of nuclear or super-
natant fractions except perhaps, with the latter fraction, after 38 days of dye
feeding.
There are few reports on RNA levels in fractions from primary liver tumours.
With hepatomas induced by 2-acetylaminofluorene, there may be an increase in
nuclearRNA relative to cytoplasmic RNA (Rutman, Cantarow and Paschkis, 1954)
but, in apparent disagreement with the present results, no marked decrease in
microsomal RNA (Laird and Miller, 1953). Of greatest relevance to the present
findings is the report by Peterman et al. (1956) on the ribonucleoprotein particles
which form one constituent of microsomal fractions. These particles were not
markedly diminished in amount (per gramme of tissue) in hepatomas, whereas a
markedfallhas now been observed with the RNA of the whole microsomal fraction
as now prepared. There is evidence to suggest that microsomal fractions contain
different types of RNA, possibly with different loci in the microsomal structure
(Kuff and Hogeboom, 1956; Chauveau, Moul6 and Rouiller, 1957; Reid and
Stevens, 1958), and it is possible that the decrease found with hepatomas is
confined to RNA other than that located in the ribonucleoprotein particles.
There are many pitfalls in the interpretation of isotopic incorporation experi-
ments in terms of changes in rate of synthesis. Determination of the labelling of
RNA is not informative unless the precursor pool is also studied. With hepatomas,
there is relatively poor absorption of injected precursors (Zamecnik, Loftfield,
Stephenson and Steele, 1951); indeed in Zamecnik's laboratory no detectable
labelling was found in the acid-soluble fraction of RNA or hepatomas, in contrast
with normal liver, when orotic acid was given at doses of the order of 2,uc (Scott,
1957, personal communication). However, in the present experiments, with doses
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of 22 ,uc or greater, the radioactivity ofthe acid-soluble fraction and ofRNA was
ample to allow of accurate counting (at least 5 times background).
With the radioactivity ofthe whole acid-soluble fraction as the basis for assess-
ing RNA radioactivity, it appeared that RNA synthesis in the nuclear and super-
natant fractions was high in hepatomas, although low in " precancerous " liver
(Fig. 3). Closer study in a few experiments, with the radioactivity ofthe supposed
precursor (uridine diphosphate) as the basis of comparison, substantiated these
tentative conclusions with hepatomas (at least for the supernatant fraction) but
not with precancerous liver. Admittedly it is not certain that uridine diphosphate
is the acid-soluble precursor of nuclear and supernatant RNA. If the precursor
were uridine triphosphate (Edmond and Abrams, 1957; Reid and Stevens, 1958),
the argument concerning hepatomas is not invalidated since, as was shown in
Fig 3 (b), the specific activity ofthe triphosphate parallels that ofthe diphosphate.
As is argued in the Results section, the rate of synthesis of microsomal RNA
in hepatomas may be decreased, rather than increased as superficial inspection of
Fig. 1 (b) and 2 might suggest. Such a decrease in synthesis would of course
account for the fall in the amount of microsomal RNA; but further proof is
needed.
The experiments on which the above arguments and tentative conclusions rest
should be regarded merely as orienting experiments on which further work can
be based. One difficulty in interpreting the results is that there is evidence of
heterogeneity in the RNA ofthe microsomal and supernatant fractions (Reid and
Stevens, 1957, 1958) and also ofthe nuclear fraction (Logan and Davidson, 1957;
Allfrey andMirsky, 1957). The study ofdifferent RNA constituents in microsomal
andsupernatantfractionsfromprecancerousand cancerousliveris nowinprogress.
Hitherto there have been few studies of precancerous liver or primary
hepatomas with respect to the incorporation of injected precursors into RNA,
and no attempts to discuss changes in rate ofRINA synthesis (Heidelberger, 1953).
Griffin, Davis and Tifft (1952) studied the labelling of RNA in precancerous liver
and hepatomas after injection of labelled adenine, and found that the amount of
label in nuclear RNA was somewhat increased, relative to the amount in cyto-
plasmic RNA, in the hepatomas. In these experiments, and in experiments with
labelled phosphate (Ward and Griffin, 1955), there was no increase in nuclear
RNA labelling with precancerous liver. In other experiments with phosphate
(Brues, Tracy and Cohn, 1944; Albert and Johnson, 1954; Daoust and Cantero,
1955; Grant and Rees, 1958), the conditions were such that no comparison can
be made with the results now obtained. In vitro experiments on whole tissue,
such as those of Canellakis (1957) who incubated transplanted hepatoma tissue
with various RNA precursors (see also Weed, 1951, and Belousova, 1955), are
likewise not readily comparable with the present experiments. Here it should be
emphasized that orotic acid, as now used, is a particularly specific and " physio-
logical " precursor (Hurlbert and Potter, 1954); uracil itself is poorly utilized by
normal liver, although it is utilized to some extent by precancerous liver or
hepatomas (Rutman, Cantarow and Paschkis, 1954).
The data for the labelling of different uridine nucleotides in the acid-soluble
fraction have been discussed above in relation to changes in the levels of these
nucleotides. Daoust and Cantero (1955) studied the labelling of constituents of
the acid-soluble fraction from liver tumours (mixed hepatoma and cholangioma),
after injection of labelled phosphate; but their results are difficult to compare
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with those now reported, particularly since their chromatographic methods for
separation of nucleotides were less satisfactory than those now available.
SUMMARY
The amounts of ribonucleic acid (RNA) and of fat-free tissue solid (essentially
protein) were determined in tissue fractions from rats fed 3'-methyl-4-dimethyl-
aminoazobenzene so as to furnish hepatomas, liver distant from tumours, and
(with brief dye-feeding) " precancerous " liver. Hepatomas showed a marked
fall in microsomal RNA and solid, whereas precancerous liver showed decreases
in the RNA andl solids of the nuclear and mitochondrial fractions and also in
microsomal RNA.
With these tissues, a study was made of the labelling of RNA and of acid-
soluble nucleotides after injection of labelled orotic acid. The labelling of RNA,
in comparison with that of the whole acid-soluble fraction, was low for nuclear
and supernatant fractions with precancerous liver and high with hepatomas.
More detailed results obtained in a few experiments suggest (but do not prove)
that with hepatomas the rate of synthesis of RNA from the supposed imme-
diate precursor is increased in supernatant (and possibly nuclear) fractions but
decreased in the microsomal fraction. Data for the labelling of various uridine
nucleotides are discussed in relation to the changes in their levels reported in the
preceding paper (Reid and Lotz, 1958).
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